2 months ago
PRLB
AnalystsRobert WassermanRobert Wasserman's Stock Forecasts
AnalystsRobert Wasserman
Analyst Ranking
Top 18%
#964 out of 5511 analysts
Average Return
+6.11%
Win Rate
51%62 out of 121
Risk vs Reward
Poor
Good
Robert Wasserman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mindwalk Holdings CorpHYFT | +213.89% | $0.36 | $1.13 | 2025-04-01 - 2026-03-31 | Buy |
Mindwalk Holdings CorpHYFT | +192.65% | $0.68 | $1.99 | 2024-08-14 - 2025-08-13 | Buy |
Molekule Group IncMKULQ | +174.00% | $5.00 | $13.70 | 2022-02-01 - 2022-06-14 | Buy |
Nephros IncNEPH | +164.02% | $1.64 | $4.33 | 2024-11-12 - 2025-11-11 | Buy |
Ligand Pharmaceuticals IncLGND | +119.54% | $92.48 | $203.03 | 2020-02-06 - 2021-02-05 | Strong Buy |
Robert Wasserman Analyst Color
Get additional color on Robert Wasserman's coverage of popular stocks
7 months ago
HALO
10 months ago
LGND
10 months ago
PRLB
a year ago
LGND
2 years ago
ITGR
2 years ago
LGND
Robert Wasserman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Integer Holdings CorpITGR | 14 | Hold | N/A | N/A | Downgrades | a month ago |
Biolife Solutions IncBLFS | 7 | Hold | N/A | N/A | Downgrades | a month ago |
Repligen CorpRGEN | 4 | Strong Buy | $185.00 | +5.88% | Upgrades | 2 months ago |
Abcellera Biologics IncABCL | 7 | Strong Buy | $11.00 | -3.59% | Upgrades | 2 months ago |
Regeneron Pharmaceuticals IncREGN | 1 | Strong Buy | $185.00 | -76.10% | Upgrades | 2 months ago |
Proto Labs IncPRLB | 8 | Strong Buy | $91.00 | +15.06% | Maintains | 2 months ago |
Bio Techne CorpTECH | 8 | Hold | N/A | N/A | Downgrades | 3 months ago |
Halozyme Therapeutics IncHALO | 11 | Strong Buy | $90.00 | -15.29% | Maintains | 7 months ago |
Ligand Pharmaceuticals IncLGND | 12 | Strong Buy | $220.00 | -20.57% | Maintains | 10 months ago |
Intensity Therapeutics IncINTS | 7 | Buy | $37.50 | N/A | Maintains | a year ago |
Kamada LtdKMDA | 2 | Strong Buy | $15.00 | N/A | Reiterates | a year ago |
Omniab IncOABI | 9 | Strong Buy | $6.00 | N/A | Reiterates | a year ago |
Xoma Royalty CorpXOMA | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Mindwalk Holdings CorpHYFT | 6 | Buy | $3.00 | N/A | Reiterates | a year ago |
Anebulo Pharmaceuticals IncANEB | 6 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Nephros IncNEPH | 3 | Buy | $5.00 | N/A | Reiterates | 2 years ago |
Emergent Biosolutions IncEBS | 17 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Codexis IncCDXS | 7 | Hold | N/A | N/A | Reiterates | 2 years ago |
Alterity Therapeutics LtdATHE | 1 | Buy | $4.00 | N/A | Reiterates | 3 years ago |
Processa Pharmaceuticals IncPCSA | 1 | Buy | $100.00 | N/A | Reiterates | 3 years ago |
Molekule Group IncMKULQ | 4 | Buy | $7.00 | N/A | Reiterates | 3 years ago |
Fortress Biotech IncFBIO | 1 | Buy | $75.00 | N/A | Reiterates | 3 years ago |
Danaher CorpDHR | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Thermo Fisher Scientific IncTMO | 1 | Strong Buy | $580.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.